Morning Bul (Gedik Yatırım)

Push & Pull
 
Today we expect a cautious opening with some positive touch in early trades tracking the gains in global markets overnight. TRY is being flattish around 18,81 levels early in the morning, just like we have seen in last 3 months. Index will probably test 4500 100 dma levels in following days. 5000 - 4,500 are strong resistance and support levels.
  
 
 
Stock in Trade
• TSKB (TSKB TI, Marketperform, TP TL4.62/share) Q4 22 results - Solid income from participations and 35% ROE guided for 2023 (Neutral)
• Share buyback / Insider buys: SAHOL (710k - 0.03%), ALARK (6k - 0.01%), MPARK (28k - 0.01%), LKMNH (20k - 0.06%), MEDTR (18.9 - 0.02%), INDES (60k - 0.02%), ORGE (100k - 0.12%)
 
 
Economic Calendar
• Feb 02: 4Q22 Financial Results Announcements: ANHYT (Cons: NI: TL332mn /Gedik: -), TOASO (Cons: NS: TL22.742mn - EBITDA: TL3.609mn - NI: TL2.724mn /Gedik: NS: TL22.742mn - EBITDA: TL3.561mn - NI: TL2.814mn) and YKBNK (Cons: NI: TL16.374mn /Gedik: NI: TL15.849mn)
• Feb 03: CPI, Jan (Prior: MoM - 1,18%, YoY - 64,27%)
• Feb 03: 4Q22 Financial Results Announcements: SISE (Cons: NS: TL29.102mn - EBITDA: TL5.779mn - NI: TL4.675mn /Gedik: NS: TL28.921mn - EBITDA: TL5.747mn - NI: TL4.981mn)
• Feb 06: Effective Exchange Rate, Jan (Prior: 54,66)
• Feb 06: 4Q22 Financial Results Announcements: ISCTR (Cons: NI: TL19.346mn /Gedik: NI: TL19.346mn) and TTRAK (Cons: NS: TL7.193mn - EBITDA: TL1.113mn - NI: TL822mn /Gedik: NS: TL7.124mn - EBITDA: TL1.154mn - NI: TL862mn)
• Feb 07: Cash Budget Balance, Jan (Prior: -108.3b)
• Feb 07: 4Q22 Financial Results Announcements: AKGRT (Cons: NI: TL87mn /Gedik: -)
• Feb 08: 4Q22 Financial Results Announcements: AYGAZ (Cons: NS: TL10.184mn - EBITDA: TL81mn - NI: TL1.326mn /Gedik: NS: TL10.114mn - EBITDA: TL69mn - NI: TL1.347mn) & FROTO (Cons: NS: TL60.785mn - EBITDA: TL6.410mn - NI: TL5.754mn /Gedik: NS: TL60.464mn - EBITDA: TL6.218mn - NI: TL5.567mn) & TUPRS (Cons: NS: TL126.313mn - EBITDA: TL15.348mn - NI: TL13.770mn /Gedik: NS: TL131.418mn - EBITDA: TL16.934mn - NI: TL13.888mn)
• Feb 10: Unemployment Rate, Dec (Prior: 10,20%)
• Feb 10: Industrial Production, Dec (Prior: MoM: -1,10% / YoY: -1,30%)
• Feb 10: 4Q22 Financial Results Announcements: KCHOL (Cons: TL21.012mn /Gedik:-)
• Feb 13 Retail Trade WDA YoY, Dec (Prior: 12,10%)
• Feb 13: 4Q22 Financial Results Announcements: TTKOM (Cons: NS: TL14.440mn - EBITDA: TL5.590mn - NI: TL1.229mn /Gedik: NS: TL14.440mn - EBITDA: TL5.590mn - NI: TL2.387mn)
• Feb 14: 4Q22 Financial Results Announcements: TAVHL (Cons: NS: TL4.974mn - EBITDA: TL1.060mn - NI: -TL117mn /Gedik: -) & VAKBN (Cons: NI: TL7.582mn /Gedik: NI: TL7.585mn)
• Feb 15: 4Q22 Financial Results Announcements: AKSA (Cons: NS: TL4.925mn - EBITDA: TL963mn - NI: TL833mn /Gedik: NS: TL4.952mn - EBITDA: TL1.143mn - NI: TL779mn )
• Feb 17: 4Q22 Financial Results Announcements: TKNSA (Cons: - / Gedik: -)
• Feb 27: 4Q22 Financial Results Announcements: CCOLA (Cons: NS: TL12.353mn - EBITDA: TL1.656mn - NI: TL382mn /Gedik: NS: TL12.154mn - EBITDA: TL4.596mn - NI: TL320mn)
• Feb 28: 4Q22 Financial Results Announcements: AEFES (Cons: NS: TL21.756mn - EBITDA: TL3.221mn - NI: TL1mn /Gedik: NS: TL21.211mn - EBITDA: TL3.298mn - NI: -TL142mn), ASUZU (Cons: - / Gedik: -), GOODY (Cons: - / Gedik: NS: TL3.470mn - EBITDA: TL421mn - NI: TL201mn) & MGROS (Cons: NS: TL23.277mn - EBITDA: TL1.771mn - NI: TL472mn /Gedik: NS: TL23.216mn - EBITDA: TL1.738mn - NI: TL580mn)
• Mar 01: 4Q22 Financial Results Announcements: SAHOL (Cons: NI: TL10.574mn / Gedik: -), THYAO (Cons: NS: TL87.428mn - EBITDA: TL20.516mn - NI: TL6.200mn /Gedik: -), TURSG (Cons: NI: TL395mn /Gedik: -) & VESBE (Cons: NS: TL10.343mn - EBITDA: TL610mn - NI: TL98mn /Gedik: -)
• Mar 01: Deadline for unconsolidated financial statements
• Mar 07: BIMAS 4Q22 Financial Results Announcement BIMAS (Cons: NS: TL45.345mn - EBITDA: TL3.737mn - NI: TL2.188mn /Gedik: NS: TL42.427mn - EBITDA: TL3.504mn - NI: TL2.152mn)
• Mar 08: MPARK 4Q22 Financial Results Announcement (Cons: NS: TL2.886mn - EBITDA: TL689mn - NI: TL294mn /Gedik: NS: TL2.822mn - EBITDA: TL669mn - NI: TL317mn)
• Mar 09: TCELL4Q22 Financial Results Announcement (Cons: NS: TL15.735mn - EBITDA: TL6.351mn - NI: TL1.829mn /Gedik: NS: TL15.078mn - EBITDA: TL6.291mn - NI: TL2.173mn)
•
• Mar 13: 4Q22 Financial Results Announcements: TMSN (Cons: - / Gedik: -) & ZOREN (Cons: NS: TL8.454mn - EBITDA: TL2.289mn - NI: TL432mn /Gedik: -)
• Mar 13: Deadline for consolidated financial statements
• Mar 14: 4Q22 Financial Results Announcements: MAVI (Cons: NS: TL3.049mn - EBITDA: TL628mn - NI: TL231mn /Gedik: -)


 
 Gedik Yatırım Menkul Değerler A.Ş.
 www.gedik.com

                                     ***
                               Yasal Uyarı
 
 Burada yer alan yatırım bilgi, yorum ve tavsiyeler yatırım danışmanlığı kapsamında değildir.Yatırım danışmanlığı hizmeti ; aracı kurumlar, portföy yönetim şirketleri, mevduat kabul etmeyen bankalar ile müşteri arasında imzalanacak yatırım danışmanlığı sözleşmesi çerçevesinde sunulmaktadır.Burada yer alan yorum ve tavsiyeler, yorum ve tavsiyede bulunanların kişisel görüşlerine dayanmaktadır.Bu görüşler mali durumunuz ile risk ve getiri tercihlerinize uygun olmayabılır.Bu nedenle, sadece burada yer alan bilgilere dayanılarak yatırım kararı verilmesi beklentilerinize uygun sonuçlar doğurmayabilir.